Switch to
More onapp

How to use scorecard? Learn more

Sun Pharmaceutical Industries Ltd

SUNPHARMA
Health CarePharmaceuticals
LargecapWith a market cap of ₹2,33,419 cr, stock is ranked 19
Low RiskStock is 1.36x as volatile as Nifty
984.200.75 (+0.08%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Scorecard

Performance

Avg

Price return has been average, nothing exciting

Valuation

High

Seems to be overvalued vs the market average

Growth

Avg

Financials growth has been moderate for a few years

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Avg

The stock is overpriced but is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

Health CarePharmaceuticals
LargecapWith a market cap of ₹2,33,419 cr, stock is ranked 19
Low RiskStock is 1.36x as volatile as Nifty

Key MetricsEdit

No LabelNo Label
55.17
PB RatioPB Ratio
4.57
Dividend YieldDiv. Yield
1.03%
Sector PESector PE
32.70
Sector PBSector PB
4.03
Sector Div YldSctr Div Yld
0.98%

Forecast & RatingsDetailed Forecast 

87%

Analysts have suggested that investors can buy this stock

Price

Price Upside

Pro Only

Earnings

Earnings Growth

Pro Only

Revenue

Rev. Growth

Pro Only

See Detailed Forecast

Company Profile

Sun Pharmaceutical Industries Limited is a pharmaceuticals company which offers generics, branded generics, specialty products, over-the-counter products, anti-retroviral and APIs.

Brands

Revital

Health & vitamin supplement

Volini

Pain reliving spray

Investor PresentationView older 

Jan 16, 2023

PDF
View Older Presentations

Brands

Revital

Health & vitamin supplement

Volini

Pain reliving spray

Financial TrendFinancial statements 

201920202021202230.0933.4934.3639.732.673.762.903.27
Revenue
Profit
All values in ₹ Thousand cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent EventsAll events 

Trading Window 
Announced OnMar 27, 2023

Sun Pharmaceutical Industries Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 | Download

Sun Pharmaceutical Industries Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 | Download

Updates 
Announced OnMar 26, 2023

Sun Pharmaceutical Industries Limited has informed the Exchange regarding 'Further to our intimation filed on 2nd March 2023, regarding an Information Technology ( IT ) security incident, we wish to provide an update.'. | Download

Sun Pharmaceutical Industries Limited has informed the Exchange regarding 'Further to our intimation filed on 2nd March 2023, regarding an Information Technology ( IT ) security incident, we wish to provide an update.'. | Download

Cash Dividend 
Ex. DateFeb 8, 2023

Interim • Div/Share: ₹ 7.5

See all events